Clinical Trials
6
Active:0
Completed:5
Trial Phases
1 Phases
Phase 4:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Phase 4
4 (100.0%)Clinical Outcomes of Patients with LAL+ in At Least One Eye
- Conditions
- IOL, Cataract
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Target Recruit Count
- 25
- Registration Number
- NCT06650358
- Locations
- πΊπΈ
Bucci Laser Vision Institute, Wilkes-Barre, Pennsylvania, United States
Pharmacokinetics of Aqueous Dexamethasone
Phase 4
Completed
- Conditions
- PharmacokineticsAqueous DexamethasoneInflammatory Cytokine Response
- Interventions
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Target Recruit Count
- 102
- Registration Number
- NCT04667507
- Locations
- πΊπΈ
Bucci Laser Vision, Wilkes-Barre, Pennsylvania, United States
Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification
- First Posted Date
- 2011-02-15
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Target Recruit Count
- 120
- Registration Number
- NCT01296191
- Locations
- πΊπΈ
Bucci Laser Vision Institute, Wilkes-Barre, Pennsylvania, United States
Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the Opposite
Completed
- Conditions
- Cataract
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Target Recruit Count
- 175
- Registration Number
- NCT01253239
- Locations
- πΊπΈ
Bucci Laser Vision Institute, Wilkes-Barre, Pennsylvania, United States
A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
Phase 4
Completed
- Conditions
- Cataracts
- Interventions
- First Posted Date
- 2009-11-30
- Last Posted Date
- 2011-08-31
- Lead Sponsor
- Frank A. Bucci, Jr., M.D.
- Target Recruit Count
- 126
- Registration Number
- NCT01021761
- Prev
- 1
- 2
- Next
News
No news found